The Leadership Team at NewLink Genetics is responsible for setting the strategic direction of the company, guiding its clinical and commercial initiatives in immuno-oncology. This team, comprised of executives with diverse expertise in finance, science, and medicine, collaborates to drive innovation, oversee research and development, and ensure effective resource allocation to bring cutting-edge cancer therapies to market.
View all